[
1. COVID-19 CORONAVIRUS PANDEMIC, available online: https://www.worldometers.info/coronavirus/, accessed on 21 November 2022.
]Search in Google Scholar
[
2. Thakur V, Ratho RK, Kumar P, Bhatia SK, Bora I, Mohi GK, et al. Multi-Organ Involvement in COVID-19: Beyond Pulmonary Manifestations. J Clin Med. 2021 Jan 24;10(3):446. DOI: 10.3390/jcm10030446786618933498861
]Open DOISearch in Google Scholar
[
3. Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020 Jul;26(7):1017-32. DOI: 10.1038/s41591-020-0968-332651579
]Open DOISearch in Google Scholar
[
4. Fu EL, Janse RJ, de Jong Y, van der Endt VHW, Milders J, van der Willik EM, et al. Acute kidney injury and kidney replacement therapy in COVID-19: a systematic review and meta-analysis. Clin Kidney J. 2020 Sep 2; 13(4): 550-63. DOI: 10.1093/ckj/sfaa160746759332897278
]Open DOISearch in Google Scholar
[
5. Głowacka M, Lipka S, Młynarska E, Franczyk B, Rysz J. Acute Kidney Injury in COVID-19. Int J Mol Sci. 2021 Jul 28;22(15):8081. DOI: 10.3390/ijms22158081834753634360866
]Open DOISearch in Google Scholar
[
6. He W, Liu X, Hu B, Li D, Chen L, Li Y, et al. Gender and Ethnic Disparities of Acute Kidney Injury in COVID-19 Infected Patients: A Literature Review. Front Cell Infect Microbiol. 2022 Jan 13;11:778636. DOI: 10.3389/fcimb.2021.778636882317935145920
]Open DOISearch in Google Scholar
[
7. Toth-Manikowski SM, Caldwell J, Joo M, Chen J, Meza N, Bruinius J, et al; STOP-COVID Investigators. Sex-related differences in mortality, acute kidney injury, and respiratory failure among critically ill patients with COVID-19. Medicine (Baltimore). 2021 Dec 17;100(50):e28302. DOI: 10.1097/MD.0000000000028302867798934918709
]Open DOISearch in Google Scholar
[
8. Jin JM, Bai P, He W, Wu F, Liu XF, Han DM, et al. Gender Differences in Patients With COVID-19: Focus on Severity and Mortality. Front Public Health. 2020 Apr 29;8:152. DOI: 10.3389/fpubh.2020.00152720110332411652
]Open DOISearch in Google Scholar
[
9. El Mouhayyar C, Dewald J, Cabrales J, Tighiouart H, Moraco AH, Jaber BL, et al. Factors Associated with Severity of Acute Kidney Injury and Adverse Outcomes in Critically Ill Patients with COVID-19. Nephron. 2022 Jun 8: 1-9. DOI: 10.1159/000524657939377635675790
]Open DOISearch in Google Scholar
[
10. Nguyen NT, Chinn J, De Ferrante M, Kirby KA, Hohmann SF, Amin A. Male gender is a predictor of higher mortality in hospitalized adults with COVID-19. PLoS One. 2021 Jul 9; 16(7): e0254066. DOI: 10.1371/journal.pone.0254066827014534242273
]Open DOISearch in Google Scholar
[
11. Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020 Apr 16; 181(2): 271-80.e8. DOI: 10.1016/j.cell.2020.02.052710262732142651
]Open DOISearch in Google Scholar
[
12. Khan S, Chen L, Yang CR, Raghuram V, Khundmiri SJ, Knepper MA. Does SARS-CoV-2 Infect the Kidney? J Am Soc Nephrol. 2020 Dec;31(12):2746-8. DOI: 10.1681/ASN.2020081229779020333051359
]Open DOISearch in Google Scholar
[
13. Mikkonen L, Pihlajamaa P, Sahu B, Zhang FP, Jänne OA. Androgen receptor and androgen-dependent gene expression in lung. Mol Cell Endocrinol. 2010 Apr 12; 317(1-2):14-24. DOI: 10.1016/j.mce.2009.12.02220035825
]Open DOISearch in Google Scholar
[
14. Stelzig KE, Canepa-Escaro F, Schiliro M, Berdnikovs S, Prakash YS, Chiarella SE. Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in differentiated airway epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2020 Jun 1;318(6):L1280-1. DOI: 10.1152/ajplung.00153.2020727698232432918
]Open DOISearch in Google Scholar
[
15. O’Brien J, Du KY, Peng C. Incidence, clinical features, and outcomes of COVID-19 in Canada: impact of sex and age. J Ovarian Res. 2020 Nov 24; 13(1):137. DOI: 10.1186/s13048-020-00734-4768485433234144
]Open DOISearch in Google Scholar
[
16. Wenzhong, L.; Hualan, L. COVID-19: Attacks the 1-beta Chain of Hemoglobin to Disrupt Respiratory Function and Escape Immunity. ChemRxiv 2022, Cambridge Open Engage, available online: doi: 10.26434/chemrxiv-2021-dtpv3-v11. DOI: 10.26434/chemrxiv-2021-dtpv3-v11
]Open DOISearch in Google Scholar
[
17. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2013, Suppl 3,1-150.
]Search in Google Scholar
[
18. Kaushal K, Kaur H, Sarma P, Bhattacharyya A, Sharma DJ, Prajapat M, et al. Serum ferritin as a predictive biomarker in COVID-19. A systematic review, meta-analysis and meta-regression analysis. J Crit Care. 2022 Feb; 67: 172-181. DOI: 10.1016/j.jcrc.2021.09.023860455734808527
]Open DOISearch in Google Scholar
[
19. Ahmed S, Jafri L, Hoodbhoy Z, Siddiqui I. Prognostic Value of Serum Procalcitonin in COVID-19 Patients: A Systematic Review. Indian J Crit Care Med. 2021 Jan;25(1):77-84. DOI: 10.5005/jp-journals-10071-23706787429133603306
]Open DOISearch in Google Scholar
[
20. Chan YL, Tseng CP, Tsay PK, Chang SS, Chiu TF, Chen JC. Procalcitonin as a marker of bacterial infection in the emergency department: an observational study. Crit Care. 2004 Feb;8(1):R12-20. DOI: 10.1186/cc239642005814975050
]Open DOISearch in Google Scholar
[
21. Meisner M, Lohs T, Huettemann E, Schmidt J, Hueller M, Reinhart K. The plasma elimination rate and urinary secretion of procalcitonin in patients with normal and impaired renal function. Eur J Anaesthesiol. 2001 Feb;18(2): 79-87. DOI: 10.1097/00003643-200102000-00004
]Open DOISearch in Google Scholar
[
22. Sun Y, Jiang L, Shao X. Predictive value of procalcitonin for diagnosis of infections in patients with chronic kidney disease: a comparison with traditional inflammatory markers C-reactive protein, white blood cell count, and neutrophil percentage. Int Urol Nephrol. 2017 Dec;49(12):2205-16. DOI: 10.1007/s11255-017-1710-z28956241
]Open DOISearch in Google Scholar
[
23. Wu SC, Liang CX, Zhang YL, Hu WP. Elevated serum procalcitonin level in patients with chronic kidney disease without infection: A case-control study. J Clin Lab Anal. 2020 Feb;34(2):e23065. DOI: 10.1002/jcla.23065703159231617251
]Open DOISearch in Google Scholar
[
24. Nakamura Y, Murai A, Mizunuma M, Ohta D, Kawano Y, Matsumoto N, et al. Potential use of procalcitonin as biomarker for bacterial sepsis in patients with or without acute kidney injury. J Infect Chemother. 2015 Apr; 21(4): 257-63. DOI: 10.1016/j.jiac.2014.12.00125677555
]Open DOISearch in Google Scholar
[
25. Chun K, Chung W, Kim AJ, Kim H, Ro H, Chang JH, et al. Association between acute kidney injury and serum procalcitonin levels and their diagnostic usefulness in critically ill patients. Sci Rep. 2019 Mar 18;9(1):4777. DOI: 10.1038/s41598-019-41291-1642301930886220
]Open DOISearch in Google Scholar
[
26. Takahashi G, Shibata S, Fukui Y, Okamura Y, Inoue Y. Diagnostic accuracy of procalcitonin and presepsin for infectious disease in patients with acute kidney injury. Diagn Microbiol Infect Dis. 2016 Oct; 86(2): 205-10. DOI: 10.1016/j.diagmicrobio.2016.07.01527489118
]Open DOISearch in Google Scholar
[
27. Kan WC, Huang YT, Wu VC, Shiao CC. Predictive Ability of Procalcitonin for Acute Kidney Injury: A Narrative Review Focusing on the Interference of Infection. Int J Mol Sci. 2021 Jun 27;22(13):6903. DOI: 10.3390/ijms22136903826824934199069
]Open DOISearch in Google Scholar
[
28. Dong R, Wan B, Lin S, Wang M, Huang J, Wu Y, et al. Procalcitonin and Liver Disease: A Literature Review. J Clin Transl Hepatol. 2019 Mar 28;7(1):51-5. DOI: 10.14218/JCTH.2018.00012644164830944820
]Open DOISearch in Google Scholar
[
29. Elefsiniotis IS, Skounakis M, Vezali E, Pantazis KD, Petrocheilou A, Pirounaki M, et al. Clinical significance of serum procalcitonin levels in patients with acute or chronic liver disease. Eur J Gastroenterol Hepatol. 2006 May; 18(5): 525-30. DOI: 10.1097/00042737-200605000-0001216607149
]Open DOISearch in Google Scholar
[
30. McGonagle D, Ramanan AV, Bridgewood C. Immune cartography of macrophage activation syndrome in the COVID-19 era. Nat Rev Rheumatol. 2021 Mar;17(3):145-7. DOI: 10.1038/s41584-020-00571-1786361533547426
]Open DOISearch in Google Scholar
[
31. Kell DB, Pretorius E. Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells. Metallomics. 2014 Apr;6(4):748-73. DOI: 10.1039/C3MT00347G24549403
]Open DOISearch in Google Scholar
[
32. Crayne CB, Albeituni S, Nichols KE, Cron RQ. The Immunology of Macrophage Activation Syndrome. Front Immunol. 2019 Feb 1;10:119. DOI: 10.3389/fimmu.2019.00119636726230774631
]Open DOISearch in Google Scholar
[
33. Pál K, Molnar AA, Huțanu A, Szederjesi J, Branea I, Timár Á, et al. Inflammatory Biomarkers Associated with In-Hospital Mortality in Critical COVID-19 Patients. Int J Mol Sci. 2022 Sep;23(18):10423. DOI: 10.3390/ijms231810423949935236142336
]Open DOISearch in Google Scholar
[
34. Carubbi F, Salvati L, Alunno A, Maggi F, Borghi E, Mariani R, et al. Ferritin is associated with the severity of lung involvement but not with worse prognosis in patients with COVID-19: data from two Italian COVID-19 units. Sci Rep 2021 Mar;11(1):4863. DOI: 10.1038/s41598-021-83831-8792138633649408
]Open DOISearch in Google Scholar
[
35. Ghio AJ, Ford ES, Kennedy TP, Hoidal JR. The association between serum ferritin and uric acid in humans. Free Radic Res. 2005 Mar;39(3):337-42. DOI: 10.1080/1071576040002608815788238
]Open DOISearch in Google Scholar
[
36. Raimondi F, Novelli L, Ghirardi A, Russo FM, Pellegrini D, Biza R, et al. Covid-19 and gender: lower rate but same mortality of severe disease in women-an observational study. BMC Pulm Med. 2021 Mar 20;21(1):96. DOI: 10.1183/13993003.congress-2021. PA3663
]Open DOISearch in Google Scholar
